Table 3.
Surgical outcomes after robotic PD
| Aberrant RHA group (n = 15) | Normal RHA group (n = 58) | P value | |
|---|---|---|---|
| Conversion to open | >0.05 | ||
| Subcutaneous emphysema | 2 | ||
| Cancer encasing aRHA | 1 | ||
| Friable tissue | 1 | ||
| Bleeding | 1 | ||
| Severe adhesion of bowel | 1 | ||
| Other | 1 | ||
| Operation time (min)a | 443.7 ± 50.1 | 463.6 ± 105.2 | >0.05 |
| Estimated blood loss (ml)a | 545.8 ± 729.0 | 310.1 ± 267.6 | >0.05 |
| Transfusiona | >0.05 | ||
| No | 7 | 45 | |
| Yes | 5 | 9 | |
| Liver function test (POD#7)a | >0.05 | ||
| Bilirubin | 0.8 ± 0.2 | 1.1 ± 1.5 | |
| AST | 29.8 ± 17.4 | 31.2 ± 16.8 | |
| ALT | 35.4 ± 39.3 | 41.0 ± 44.4 | |
| Complicationsa | >0.05 | ||
| No | 7 | 25 | |
| Yes | 5 | 29 | |
| Pancreatic fistulaa | 2 | 11 | >0.05 |
| Grade A | 0 | 6 | |
| Grade B | 1 | 4 | |
| Grade C | 1 | 1 | |
| Bile leakagea | 0 | 1 | >0.05 |
| Postoperative bleedinga | 1 | 5 | >0.05 |
| Reoperationa | 2 | 4 | >0.05 |
| Length of hospital stay (day)a | 12.7 ± 9.3 | 13.3 ± 6.9 | >0.05 |
| Mortalitya | 0 | 2 | >0.05 |
POD, postoperative day; AST, aspartate aminotransaminase; ALT, alanine aminotransferase.
a
Excluding conversion to open.